Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $9.0 million.

  • CytomX Therapeutics' Non-Current Assets fell 3894.33% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year decrease of 3371.11%. This contributed to the annual value of $13.2 million for FY2024, which is 2984.73% down from last year.
  • According to the latest figures from Q3 2025, CytomX Therapeutics' Non-Current Assets is $9.0 million, which was down 3894.33% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, CytomX Therapeutics' Non-Current Assets ranged from a high of $131.4 million in Q2 2021 and a low of $9.0 million during Q3 2025
  • Over the past 5 years, CytomX Therapeutics' median Non-Current Assets value was $21.4 million (recorded in 2023), while the average stood at $31.9 million.
  • In the last 5 years, CytomX Therapeutics' Non-Current Assets surged by 27341.23% in 2021 and then plummeted by 7987.33% in 2022.
  • Over the past 5 years, CytomX Therapeutics' Non-Current Assets (Quarter) stood at $29.1 million in 2021, then decreased by 18.28% to $23.8 million in 2022, then decreased by 20.74% to $18.9 million in 2023, then fell by 29.85% to $13.2 million in 2024, then crashed by 31.68% to $9.0 million in 2025.
  • Its Non-Current Assets was $9.0 million in Q3 2025, compared to $10.4 million in Q2 2025 and $11.9 million in Q1 2025.